Study to overcome metastasis and targeted drug-resistance of lung cancer
| Project/Area Number |
24390209
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Partial Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Respiratory organ internal medicine
|
|---|
| Research Institution | Kanazawa University |
|---|
Principal Investigator |
YANO Seiji 金沢大学, がん進展制御研究所, 教授 (30294672)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
EBI Hiromichi 金沢大学, がん進展制御研究所, 助教 (00645145)
OHTSUBO Koshiro 金沢大学, 大学病院, 講師 (60361987)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥18,200,000 (Direct Cost: ¥14,000,000、Indirect Cost: ¥4,200,000)
Fiscal Year 2014: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2013: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥9,620,000 (Direct Cost: ¥7,400,000、Indirect Cost: ¥2,220,000)
|
|---|
| Keywords | 分子標的薬耐性 / 脳転移 / 骨転移 / がん性胸膜炎 / 転移 / イメージング / がん性胸水 / がん性髄膜炎 / 肺がん / ALK阻害薬耐性 / BIM遺伝子多型 / EGFR阻害薬耐性 / mTOR阻害薬 / 個別化医療 / ボリノスタット |
|---|
| Outline of Final Research Achievements |
To elucidate mechanism of targeted drug resistance in metastatic lesions, we established in vivo imaging models for pleural carcinomatosis and bone/brain metastases, which are resistant to targeted drugs, of EGFR mutant or ALK fusion positive lung cancer cell lines. We found that resistant tumors consist of a heterogeneous mixture of functionally distinct cancer cells with different resistant mechanisms. Moreover, our observation indicated that we should be careful for toxicity of combined therapy which overcome targeted drug resistance caused by multiple mechanisms.
|
Report
(4 results)
Research Products
(53 results)
-
[Journal Article] Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma2018
Author(s)
Sakai, E., Nakayama, M., Oshima, H., Kouyama, Y., Niida, A., Fujii, S., Ochiai, A., Nakayama, K. I., Mimori, K., Suzuki, Y., Hong, C. P., Ock, C. Y., Kim, S. J. and Oshima, M.
-
Journal Title
Cancer Research
Volume: in press
Pages: 1283-1295
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
[Journal Article] Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas2017
Author(s)
Ola Rizq, Naoya Mimura, Motohiko Oshima, Atsunori Saraya, Shuhei Koide, Yuko Kato, Kazumasa Aoyama, Yaeko Nakajima-Takagi, Changshan Wang, Tetsuhiro Chiba, Anqi Ma, Jian Jin, Tohru Iseki, Chiaki Nakaseko, and Atsushi Iwama
-
Journal Title
Clinical cancer research
Volume: 23(16)
Pages: 1114-1114
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma.2012
Author(s)
Kurai J, Chikumi HT, Hamada H, Yano S, , Hashimoto K, Takata M, Sako T, Yamaguchi K, Kinoshita N, Watanabe M, Touge H, Makino H, Igishi Shimizu E
-
Journal Title
Int J Oncol
Volume: 41
Pages: 1610-1618
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
